CHICAGO, Dec. 21, 2011 /PRNewswire-USNewswire/ -- Despite the numerous medical advances that happen every day, the infant mortality rate in the United States is still higher than most European countries. While experts believe this is closely linked to the growing rate of pre-term births, researchers are committed to finding ways to make labor and delivery safer. Northwestern Medicine® researchers are examining a new device that may support improved newborn health at delivery through closer monitoring of infant oxygen use during labor.
"Poor birth outcomes are often directly related to loss of oxygen during labor and delivery," explained Alan Peaceman, MD, chief of maternal fetal medicine at Northwestern Memorial Hospital and professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine who is the lead investigator on the study. "Through more advanced monitoring, we hope to identify red flags sooner and prevent dips in oxygen that may lead to long-term health issues for the baby."
STAN™ is fetal heart rate monitoring system that measures and tracks the electrical activity of the baby's heart via an internal electrode, along with uterine contractions and how well the baby uses oxygen during labor. It then interprets the data and signals clinicians when a significant change in oxygen levels or heart rate occurs. The monitor is approved by the Food and Drug Administration and is routinely used in Europe, but has not been widely adopted in the United States yet. At present, it is only available for patients enrolled in the study. If this study demonstrates improved outcomes, it is likely that